Aoxin Q & M Dental Group Limited Announces Major Share Placement and Performance Share Plan Amendments

Key Highlights for Investors

• Proposed Placement: Up to 134,000,000 new ordinary shares to be issued at S\$0.1566 per share.
• Performance Share Plan Update: Amendments to the Aoxin Q & M Performance Share Plan (PSP) allow for new shares to be issued based on awards granted under the revised plan.
• Regulatory Approval: The company has received listing and quotation notice (LQN) from the Singapore Exchange (SGX-ST) for both the placement shares and new shares pursuant to the PSP, subject to shareholder approval and compliance with SGX-ST requirements.
• Shareholder Approval: Approval for the upsized placements was obtained at the Extraordinary General Meeting held on 27 April 2026.
• Timing: Placement shares must be placed out within seven market days from either the date of the General Meeting or the LQN, whichever is later.
• Disclosure: The LQN is not an indication of the merits of the placements, new shares, PSP, or the company and its securities.

Details of the Proposed Share Placement

Aoxin Q & M Dental Group Limited is set to issue up to 134 million new ordinary shares at a placement price of S\$0.1566 per share. This substantial capital raising exercise is part of the company’s “Upsized Placements,” which may have a significant impact on the company’s capital structure and liquidity.

The placement was subject to shareholder approval, which was secured during the extraordinary general meeting on 27 April 2026. With regulatory clearance from SGX-ST for listing and quotation, the company is required to place out the shares within seven market days from the later of the general meeting or the LQN issuance.

Investors should note that the placement price may be sensitive, as it could affect the share value depending on demand, dilution effects, and market sentiment regarding the company’s growth prospects and use of proceeds.

Amended Performance Share Plan (PSP)

In conjunction with the placement, the company has amended its Performance Share Plan. Under the amended PSP, new shares may be issued from time to time as awards to eligible participants. This move aligns with the company’s strategy to incentivize performance and retain key talent, but also introduces potential dilution for existing shareholders.

The SGX-ST’s approval covers both the placement shares and the new shares issued under the amended PSP, subject to the company continuing to meet listing requirements.

Shareholder Considerations and Price Sensitivity

• Potential Dilution: The issuance of up to 134 million new shares plus additional shares from PSP awards will dilute existing shareholdings. Investors should assess how this may affect their percentage ownership and the company’s earnings per share.
• Placement Price vs. Market Price: The placement price of S\$0.1566 may serve as a benchmark for short-term trading but could also be perceived as undervaluing or overvaluing the company, depending on current market prices.
• Regulatory Conditions: The placements are contingent on ongoing compliance with SGX-ST requirements. Any failure may delay or jeopardize the share issue.
• Market Reaction: Such large share placements and plan amendments can be seen as either a vote of confidence in future growth or a signal of cash needs, potentially affecting market sentiment and share price volatility.
• Further Announcements: The company has indicated it will make additional announcements as developments unfold, which may introduce further price-sensitive information.

Corporate Governance and Sponsor Statement

The announcement has been reviewed by the company’s sponsor, PrimePartners Corporate Finance Pte. Ltd., but has not been examined or approved by SGX-ST. SGX-ST does not take responsibility for the contents or correctness of the announcement.

Contact details for further queries are provided: Ms. Foo Jien Jieng, PrimePartners Corporate Finance, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, [email protected].

Conclusion

The upsized share placement and amended performance share plan represent significant corporate actions for Aoxin Q & M Dental Group Limited. Shareholders and investors should closely monitor these developments, as they may materially affect the company’s share price, capital structure, and future growth prospects.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult their financial advisors before making any investment decisions. The information provided is based on company announcements and may be subject to change. The Singapore Exchange assumes no responsibility for the accuracy or completeness of this report.

View Aoxin Q & M Historical chart here